Dr. Reddy's Laboratories Limited - Bathi saben saham sajrone 12 wulan pungkasan RDY

Logo perusahaan publik Dr. Reddy's Laboratories Limited (RDY)

Dr. Reddy's Laboratories is implementing sustainable "green" chemistry and solar power generation. The optimization of cross-border raw material supplies minimizes drug shortages, thereby increasing profitability. Global production of complex generics in India ensures stable market coverage. The year-over-year EPS (TTM) history demonstrates current profit dynamics, where the -55.80 mark records this indicator.

RDY Dr. Reddy's Laboratories Limited: Bathi saben saham sajrone rolas wulan pungkasan ing interval 11.02.2024 - 18.11.2026

Dr. Reddy's - rincian analitis lan metrik utama (RDY)

- rega saham lan prakiraan rega para ahli:
Analisis wiwitan perusahaan:Dr. Reddy's Lab RDY
Produk mawa merek drreddys.com

Dr. Reddy's Laboratories (RDY) expansion into the affordable biosimilars segment across US and emerging markets directly impacts profit scalability. This trend is reflected through the calculation of the rolling year change in net income per share. This ratio measures capital generation efficiency and the business's resilience to borrowing costs. By analyzing the YoY growth in net income per share over the last 12 months, an investor determines the company's ability to maintain profitability amid harsh macroeconomic conditions.